Pasteurised Akkermansia muciniphila in supplements and foods for special medical purposes now also for adolescents from 12 years: from 2.1 × 10¹⁰ to 3.4 × 10¹⁰ cells per day, viable cells below 10 CFU/g, no extension to pregnant women

Commission Implementing Regulation (EU) 2026/391, published on 24 February 2026, amends the conditions of use of the novel food “pasteurised Akkermansia muciniphila”: food supplements and foods for special medical purposes with these bacteria may now also be intended for people aged 12–18. The application also covered pregnant and lactating women, but EFSA concluded that safety for them had not been established. The authorisation holder changed its name from A-Mansia Biotech S.A. to the Akkermansia Company SA.

Source: Commission Implementing Regulation (EU) 2026/391 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use and specific labelling requirements of the novel food “pasteurised Akkermansia muciniphila”

Lab-News